Target intelligence / Profile preview

Parathymosin (PTMS)

Target
PTMS
Molecular classification
Other (small acidic nuclear protein)
01

Overview

Parathymosin (PTMS) is a small, highly conserved, acidic nuclear protein that is widely expressed in various tissues, including the brain, where it is secreted by hypothalamic neural stem/progenitor cells and neurons[1]. PTMS is rapidly transferred into nuclei of recipient cells, where it may regulate chromatin organization through its histone-binding ability, particularly by modulating the association of linker histone H1 with nucleosomes[4]. It is involved in the regulation of transcription and in the negative regulation of cell death processes, and has been shown to mediate neuroprotective functions, including inhibition of cellular senescence in the brain[1][3]. PTMS may also play a role in immune function by interfering with prothymosin alpha-mediated pathways[3]. Although it is biologically significant and has been investigated for its potential protective roles in aging and neurodegeneration, there is no direct evidence that parathymosin is a receptor, therapeutic target, or a molecule with known interacting drugs or biomarker status. Its precise mechanisms and clinical utility are still under investigation[1][3].

Other names
ParathymosinPTMSParaTparathymosin
02

Biological functions

Histone binding (specifically affects binding of histone H1 to nucleosomes)Regulation of transcription by RNA polymerase IINegative regulation of apoptotic processPossible mediation of immune functionNeuroprotection, anti-aging effects in neurons through nuclear transfer
03

Disease associations

Neurodegenerative disease (potential protective role in aging-related brain disorders)Other (possible roles in cell senescence and immune function, but not directly implicated as a major therapeutic target)

Beyond the preview

Go deeper on Parathymosin (PTMS).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Parathymosin (PTMS).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call